Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-011004
Filing Date
2023-08-18
Accepted
2023-08-18 06:02:57
Documents
32
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mymx_10q.htm   iXBRL 10-Q 710867
2 CERTIFICATIONS mymx_ex311.htm EX-31.1 8717
3 CERTIFICATIONS mymx_ex312.htm EX-31.2 8467
4 CERTIFICATIONS mymx_ex32.htm EX-32 2080
  Complete submission text file 0001654954-23-011004.txt   3479467

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mymx-20230630.xsd EX-101.SCH 33200
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mymx-20230630_lab.xml EX-101.LAB 187680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mymx-20230630_cal.xml EX-101.CAL 33254
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mymx-20230630_pre.xml EX-101.PRE 140945
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mymx-20230630_def.xml EX-101.DEF 69723
26 EXTRACTED XBRL INSTANCE DOCUMENT mymx_10q_htm.xml XML 626307
Mailing Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066
Business Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066 011-41-21-653-45-35
MYMETICS CORP (Filer) CIK: 0000927761 (see all company filings)

EIN.: 251741849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25132 | Film No.: 231183713
SIC: 2836 Biological Products, (No Diagnostic Substances)